MedTrace Logo

Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer

NCT05979623 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 971

Last updated 2023-08-07

No results posted yet for this study

Summary

The goal of this observation study is to learn about clinicopathological characteristics and prognostic factors of stage IB NSCLC. The main question it aims to answer is wheather there is relationship between newly proposed clinicopathological features and the prognosis of stage IB NSCLC .The postoperative pathological and follow-up information of participants will be used for subsequent analysis.

Conditions

  • Stage IB Non-Small Cell Lung Carcinoma

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Di Ge, Ph.D;M.D · Zhongshan Hospital, Fudan University, Shanghai, China

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2020-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05979623 on ClinicalTrials.gov